Younger demographic (below 35- 40 years), driven by nootropics and neuroenhancers, and an aging population with neurodegenerative diseases are major factors for the rising demand for cognitive health APIs. Thinking, learning, and remembering are major factors of cognitive health intertwined with mental health, which are focused on by the WHO, health practitioners, and the global population.
On this account, the market value of Active Pharmaceutical Ingredients (API) for making CNS and mental health dosages is increasing, with a growth forecast of USD 1.7 billion by 2030 at 5.4% CAGR. Simultaneously, the global brain health supplement market is booming at USD 13.69 billion by 2034. Jatan Exports is an India-based wholesaler and exporter with full inventory of API, nutraceutical, and herbal extracts with DMF & GMP, with FDA certified plant. This has privileged us to meet professionals across the industry and share valuable data and information with you.
What is the difference between Cognitive and CNS health?
Cognitive means mental functioning and storing memory, which comprises six pillars to better define cognitive health:
- Attention- Keep focus persistent and work on multiple works
- Functioning – Reasoning, planning, and strategy making
- Memory – Memorise and recall data from previous records.
- Communication – Listen, speak, and comprehend information
- Physical coordination – Connection of your brain, eyes, and other body parts
- Emotional interpretation – Social interactions and emotional expressions
Central Nervous System (CNS is the hardware of the body, whereas cognitive properties work as software of the body. It constitutes the brain, spinal cord, and nervous system, and the nervous system API market is in high demand to support raising life expectancy and a healthy life cycle. Cognitive and CNS are getting overlapped in cognitive neuroscience with more awareness and digital awareness.
Cognitive neuroscience diseases that drive API demand
With the rise of cognitive neuroscience, health conditions that need behavioural and therapeutic remedies are driving demand for finished dosages and APIs. These active pharmaceutical ingredients drive growth for the pharmaceutical market at a significant level. Here are the names of diseases:
- Alzheimer’s disease – It’s also known as dementia, and the cause is synaptic dysfunction due to the accumulation of protein.
- Attention-Deficit or Hyperactive Disorder (ADHD) – This prefrontal cortex deficit requires dopaminergic and non-dopaminergic medicines.
- Schizophrenia – It’s psychotic symptoms caused by an imbalance of the GABA-glutamate pathway of the human brain.
Awareness & biotechnological upgradation brewing cognitive health market
Awareness, biotechnology, and preventive care are core-related factors responsible for the growth of cognitive API and medicines; some of them are:
- Smart drugs -Balancing professional and personal life requires focus and better cognitive coordination. Hence, the younger generation is in search of nootropics and neuroenhancer medicines for betterment.
- Preventive drugs for aging neurodegenerative diseases – Besides treatment, preventive drugs are on the market against aging and neurodegenerative diseases.
- Mental wellness & mood management -The present generation knows the reason of their mental unhappiness in medical terms like brain fog, anxiety, and depression. Therefore, they search for medicines to keep them healthy and happy.
- Tailored therapies – Enhanced patient-specific cognitive care has led to better compliance and the advent of APIs that are no longer generic but tailored to therapies.
- Nutraceuticals converged with pharma APIs – To blur out the line between medicines and fortified food or nutraceuticals, the makers are using pharma APIs. This is winning trust among buyers and raising the growth curve.
Medicinal APIs that are making a market for cognitive health & CNS
Here are the major category of therapeutic domains that needs Central Nervous System & cognitive health APIs:
| Therapeutic Domains | APIs | Mechanism of Action |
| Antidepresant | Fluoxetine, Fluoxetine HCL, 3Bupropion | It optimises the chemical messengers or neurotransmitters. Two major ones are serotonin and norepinephrine. |
| Alzheimer’s | Rivastigmine Tartrate, Memantine HCl | Targets NMD and inhibits acetylcholine |
| Anticraving | Naltrexone Hydrochloride | It mentally and physiologically prepares the brain to stop craving for food. Three of the chemical messengers it controls are glutamate, dopamine, and GABA |
| Anti-Dementia | Piracetam | Increases nerve cells coordination and protects against excitotoxic damage. |
| Antiepileptic/Anticonvulsants | Pregabalin, Divalproex Sodium, Eslicarbazepine Acetate | Controls the suboptimal synchronous activity of the brain; hence, controls seizures |
| Anti-insomnia | Zopiclone, Zolpidem Tartrate, Ramelteon | Regulates the sleep-wake cycle, behavioral signals, and blocks neuronal alertness |
| Antimigraine | Lasmiditan,Lasmiditan | Constricts dilated blood vessels to stop the signal of migraine pain |
| Anti-Parkinson | Rasagiline Mesylate, Ropinirole Hydrochloride, Pramipexole | It balances chemical messengers of the brain: dopamine and acetylcholine |
| Antipsychotics | Quetiapine Fumarate, Ivacaftor, Aripiprazole | Block D2 receptors in the brain mesolimbic pathway. |
| Benzodiazepines | Clonazepam | It is a positive allosteric modulator that acts on the GABA receptors in the brain. |
| Dopamine Agonist | Carbidopa | Activates dopamine receptors of the human brain. It enhances the natural dopamine to control brain activities. |
| Mood Stabilizer | Lithium Carbonate | Controls hyperactive nerve signals that swing the mood. |
| Neuroprotective | Citicoline Sodium, Tafamidis Meglumine | It prevents cell death in the neuronal pathways to keep the brain active normally. |
| Smoking Cessation | Varenicline Tartrate | Lowers dopamine levels or signals the presence of nicotine to keep the human brain away from craving nicotine. |
| Stimulant | Modafinil,Armodafinil | It is reactive on excitatory transmitters. It blocks neurotransmitter reuptake. |
| Sympathomimetic | Amphetamine Sulfate | Creates the same action as endogenous catecholamine, which is synonymous with the sympathetic nervous system. |
Jatan Exports is associated with top CNS & cognitive API manufacturers in India. We have created a pool of API with DMF and CEP, and nutraceutical extracts and herbal extracts with GMP & FDA-approved certificates. Therefore, chemical engineers, pharmacists, and herbal experts choose our products to address all their biochemical purchase requisitions. We are a one-stop trader for importers across the world and the domestic market to serve a vast catalog with high rank portfolio. We offer pharma raw materials for injectable and oral grades, lesser side effects and a single-pill regimen. To check our vast portfolio, visit our website www.jatanexports.com and keep updated by reading our regular blogs.
Leave a Reply